Bio-Techne
TECH
#1464
Rank
โ‚ฌ11.01 B
Marketcap
69,45ย โ‚ฌ
Share price
2.12%
Change (1 day)
33.10%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Revenue for Bio-Techne (TECH)

Revenue in 2024 (TTM): โ‚ฌ1.07 Billion

According to Bio-Techne's latest financial reports the company's current revenue (TTM ) is โ‚ฌ1.06 Billion. In 2023 the company made a revenue of โ‚ฌ1.03 Billion a decrease over the revenue in the year 2022 that were of โ‚ฌ1.04 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bio-Techne from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ1.07 B3.76%
2023 โ‚ฌ1.03 B-0.79%
2022 โ‚ฌ1.04 B14.83%
2021 โ‚ฌ0.90 B39.96%
2020 โ‚ฌ0.64 B-2.29%
2019 โ‚ฌ0.66 B11.56%
2018 โ‚ฌ0.59 B19.29%
2017 โ‚ฌ0.49 B-0.51%
2016 โ‚ฌ0.50 B18.03%
2015 โ‚ฌ0.42 B26.64%
2014 โ‚ฌ0.33 B40.5%
2013 โ‚ฌ0.23 B1.22%
2012 โ‚ฌ0.23 B0.05%
2011 โ‚ฌ0.23 B15.17%
2010 โ‚ฌ0.20 B10.9%
2009 โ‚ฌ0.18 B-3.76%
2008 โ‚ฌ0.19 B17.45%
2007 โ‚ฌ0.16 B1.9%
2006 โ‚ฌ0.16 B-0.59%
2005 โ‚ฌ0.16 B30.21%
2004 โ‚ฌ0.12 B1.73%
2003 โ‚ฌ0.12 B-7.54%
2002 โ‚ฌ0.13 B-4.54%
2001 โ‚ฌ0.13 B19.87%
2000 โ‚ฌ0.11 B18.48%
1999 โ‚ฌ97.21 M45.84%
1998 โ‚ฌ66.65 M24.57%
1997 โ‚ฌ53.51 M10.05%
1996 โ‚ฌ48.62 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ39.05 B 3,553.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.36 B 121.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ18.28 B 1,610.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ18.47 B 1,628.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.78 B 67.39%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚ฌ50.17 B 4,594.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.35 M-99.59%๐Ÿ‡บ๐Ÿ‡ธ USA